Atlas Trials

Syneos Health

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Syneos Health

RecordFirmDate
A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants (NCT07497503)Syneos Health2026-04-10
Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects (NCT05805618)Syneos Health2024-07-01
A Study of APL-1501 Extended Release Capsules Compared to APL-1202 Immediate Release Tablets in Healthy Volunteers (NCT06435039)Syneos Health2024-06-21
Study to Evaluate the AIO-001 in Healthy Participants (NCT06170827)Syneos Health2023-11-21
Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol (NCT05896969)Syneos Health2023-04-27
Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3 (NCT05715736)Syneos Health2023-03-08
Phase 1 Study of ATRS-2002 in Healthy Male Adults (NCT04879589)Syneos Health2022-09-01
To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects (NCT05363839)Syneos Health2022-05-06
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair (NCT05053334)Syneos Health2022-02-16
Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 (NCT05088369)Syneos Health2021-11-11
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 (NCT04993443)Syneos Health2021-09-06
First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects (NCT04893512)Syneos Health2021-06-30
First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk (NCT04925050)Syneos Health2021-06-17
Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers (NCT04885829)Syneos Health2021-05-31
First-in-Human Study of SRT-015 in Healthy Subjects. (NCT04887038)Syneos Health2021-05-03

Track Syneos Health automatically

Every clearance here is in the API, with alerts when new ones post.